Multilocus Sequence Typing of Candida tropicalis Shows the Presence of Different Clonal Clusters and Fluconazole Susceptibility Profiles in Sequential Isolates from Candidemia Patients in Sao Paulo, Brazil
Carregando...
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC MICROBIOLOGY
Citação
JOURNAL OF CLINICAL MICROBIOLOGY, v.51, n.1, p.268-277, 2013
Resumo
The profiles of 61 Candida tropicalis isolates from 43 patients (28 adults and 15 children) diagnosed with candidemia at two teaching hospitals in Sao Paulo, Brazil, were characterized by multilocus sequence typing (MLST). For the 14 patients who had bloodstream infections, 32 isolates were serially collected from their blood and/or catheters. Thirty-nine diploid sequence types (DSTs) were differentiated. According to the C. tropicalis MLST database (http://pubmlst.org/ctropicalis/), 36 DSTs and 23 genotypes identified from the 61 isolates had not previously been described. This report represents the first study to characterize sequential isolates of C. tropicalis from candidemia cases in South America. Microvariation in a single gene was found in the sequential isolates from 7 patients. The main polymorphisms occurred in the alleles of the XYR1 gene, specifically at nucleotide positions 215, 242, and 344. Macrovariation in six gene fragments was detected in the isolates from 3 patients. eBURST analysis added two new groups to this study (groups 6 and 18). Additionally, susceptibility tests indicate that 3 isolates were resistant to fluconazole. No correlation was found between the DSTs and susceptibility to fluconazole and/or selective antifungal pressure. Two patients were sequentially infected with resistant and susceptible strains. MLST is an important tool for studying the genetic diversity of multiple/sequential isolates of patients with candidemia, allowing the comparison of our data with those from other regions of the world, as well as allowing an analysis of the genetic relationship among several clones in sequential isolates from the same or different candidemia patient sites (blood or catheter).
Palavras-chave
Referências
- AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122
- Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005
- Bedini A, 2006, CLIN MICROBIOL INFEC, V12, P75, DOI 10.1111/j.1469-0691.2005.01310.x
- Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002
- Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y
- BUCHMAN TG, 1990, SURGERY, V108, P338
- Chakrabarti A, 2009, SCAND J INFECT DIS, V41, P275, DOI 10.1080/00365540902777105
- Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06
- Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011
- Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014
- Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI
- Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06
- Costa SF, 2000, J HOSP INFECT, V45, P69, DOI 10.1053/jhin.1999.0670
- Da Matta DA, 2010, MED MYCOL, V48, P757, DOI 10.3109/13693780903501689
- da Matta DA, 2007, DIAGN MICR INFEC DIS, V57, P399, DOI 10.1016/j.diagmicrobio.2006.10.011
- Ewing B, 1998, GENOME RES, V8, P175
- Ewing B, 1998, GENOME RES, V8, P186
- Falagas ME, 2010, INT J INFECT DIS, V14, P954
- FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678
- FRASER VJ, 1992, CLIN INFECT DIS, V15, P414
- Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745
- Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039
- HUNTER PR, 1989, J CLIN MICROBIOL, V27, P2156
- HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903
- Jacobsen MD, 2008, MED MYCOL, V46, P647, DOI 10.1080/13693780801986631
- Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86
- Kontoyiannis DP, 2001, CLIN INFECT DIS, V33, P1676, DOI 10.1086/323812
- Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0
- Li SY, 2009, MICROB DRUG RESIST, V15, P205, DOI 10.1089/mdr.2009.0915
- Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07
- Lott TJ, 2012, MED MYCOL, V50, P136, DOI 10.3109/13693786.2011.592153
- Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581
- Motta AL, 2010, BRAZ J INFECT DIS, V14, P441, DOI 10.1590/S1413-86702010000500004
- Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x
- Myoken Y, 2004, HAEMATOLOGICA, V89, P378
- National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS
- Nucci M, 2007, DIAGN MICR INFEC DIS, V58, P77, DOI 10.1016/j.diagmicrobio.2006.11.009
- Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08
- Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0
- Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06
- Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P121, DOI 10.1016/S0732-8893(97)00192-2
- Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09
- Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955
- Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003
- Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07
- Sipsas NV, 2009, CANCER, V115, P4745, DOI 10.1002/cncr.24507
- Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
- TAMURA K, 1993, MOL BIOL EVOL, V10, P512
- Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005
- Vigouroux S, 2006, HAEMATOL-HEMATOL J, V91, P717
- Viscoli C, 1999, CLIN INFECT DIS, V28, P1071, DOI 10.1086/514731
- Voss A, 1996, EUR J CLIN MICROBIOL, V15, P909, DOI 10.1007/BF01690507